Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renshenguben is a Traditional Chinese Medicine (TCM) formula traditionally used to tonify Qi and Yin, and nourish the lungs and kidneys. It is a complex herbal combination typically containing *Panax ginseng*, *Rehmannia glutinosa*, *Ophiopogon japonicus*, and *Asparagus cochinchinensis*, among other botanical ingredients. In clinical research, specifically a multicenter randomized controlled trial (ChiCTR2100044250) sponsored by Shandong Cancer Hospital, it is being evaluated for the treatment of cancer-related fatigue (CRF). The formula is intended to improve the quality of life and alleviate fatigue symptoms in oncology patients by addressing underlying systemic deficiencies in vital energy and essence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on renshenguben.